At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior tolerability.
Location: Denmark
Investors 4
| Date | Name | Website |
| 13.03.2026 | Jeito Capi... | jeito.life |
| 29.01.2026 | Omega Fund... | omegafunds... |
| 01.02.2026 | Avego | avego.com |
| 22.01.2026 | Andera Par... | anderapart... |
Mentions in press and media 6
| Date | Title | Description |
| 19.03.2026 | LOTTE Holdings Healthcare and Biopharmaceutical CVC Announces Investment in Alveus Therapeutics | LOTTE Holdings Healthcare and Biopharmaceutical CVC Announces Investment in Alveus Therapeutics TOKYO, JAPAN, March 19, 2026 /EINPresswire.com/ -- LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”... |
| 02.03.2026 | Alveus Therapeutics Raises $37M in Series A Extension Funding | Alveus Therapeutics Inc., a Philadelphia, PA-based clinical-stage biotechnology company, raised $37M in Series A Extension funding. The latest round included participation from Jeito Capital and Novo Holdings, joining the original Series A ... |
| 28.01.2026 | Zurich-based biotechs make headway | Virometix, a clinical-stage biotechnology company pioneering fully synthetic vaccines, announced positive data from the company’s Phase 1 trial of its lead asset V-212, a fully synthetic, serotype-independent, peptide-based vaccine designe... |
| 13.01.2026 | Alveus Therapeutics Secures $160M Series A for Obesity, Metabolic Disease Innovation | Alveus Therapeutics, a Philadelphia-based biotech company, raised $160M in Series A funding. This significant capital infusion targets advanced therapies for obesity and metabolic diseases. New Rhein, Andera Partners, and Omega Funds led th... |
| 08.01.2026 | Alveus Therapeutics Raises $160M in Series A Financing | Alveus Therapeutics, a Philadelphia, PA-based clinical-stage biotechnology company, raised $160M in Series A funding. The round was led by New Rhein Healthcare Investors, Andera Partners, and Omega Funds, with participation from Sanofi Capi... |
| - | Alveus Therapeutics | “At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior tolerability.” |